[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2010098583A3 - 스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물 - Google Patents

스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물 Download PDF

Info

Publication number
WO2010098583A3
WO2010098583A3 PCT/KR2010/001152 KR2010001152W WO2010098583A3 WO 2010098583 A3 WO2010098583 A3 WO 2010098583A3 KR 2010001152 W KR2010001152 W KR 2010001152W WO 2010098583 A3 WO2010098583 A3 WO 2010098583A3
Authority
WO
WIPO (PCT)
Prior art keywords
salts
same
compounds
novel method
intermediate compounds
Prior art date
Application number
PCT/KR2010/001152
Other languages
English (en)
French (fr)
Other versions
WO2010098583A2 (ko
Inventor
김희석
김희철
심재의
조성미
김원정
서귀현
이관순
Original Assignee
한미홀딩스 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한미홀딩스 주식회사 filed Critical 한미홀딩스 주식회사
Publication of WO2010098583A2 publication Critical patent/WO2010098583A2/ko
Publication of WO2010098583A3 publication Critical patent/WO2010098583A3/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 고지혈 관련 질환의 치료 및 예방에 유용한, 스타틴 화합물 또는 그의 염의 신규 제조방법, 및 이에 사용되는 신규 중간체에 관한 것으로, 본 발명에 따르면, 스타틴 화합물을 신규한 중간체들로부터 간편하고 효율적으로 제조할 수 있다.
PCT/KR2010/001152 2009-02-24 2010-02-24 스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물 WO2010098583A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2009-0015435 2009-02-24
KR1020090015435A KR101160152B1 (ko) 2009-02-24 2009-02-24 스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물

Publications (2)

Publication Number Publication Date
WO2010098583A2 WO2010098583A2 (ko) 2010-09-02
WO2010098583A3 true WO2010098583A3 (ko) 2011-01-06

Family

ID=42666047

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/001152 WO2010098583A2 (ko) 2009-02-24 2010-02-24 스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물

Country Status (2)

Country Link
KR (1) KR101160152B1 (ko)
WO (1) WO2010098583A2 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8912333B2 (en) * 2010-11-12 2014-12-16 Hetero Research Foundation Polymorphs of pitavastatin calcium
CN102477032B (zh) * 2010-11-26 2015-04-01 上海医药工业研究院 一类2-环丙基-4-取代苯氧基喹啉衍生物、其制备方法、中间体及其应用
CN103058925B (zh) * 2011-11-02 2015-09-02 石药集团中奇制药技术（石家庄）有限公司 一种匹伐他汀钙的制备方法
CN104447784B (zh) * 2014-12-02 2017-06-20 上海弈柯莱生物医药科技有限公司 一种他汀类药物中间体及其制备方法和应用
CN105198807B (zh) * 2015-10-24 2018-11-20 威海迪素制药有限公司 一种低内酯含量的匹伐他汀钙的制备方法
CN105481838A (zh) * 2015-11-18 2016-04-13 北京万全德众医药生物技术有限公司 一种制备匹伐他汀内酯杂质的方法
CN105646369A (zh) * 2015-12-30 2016-06-08 安徽美诺华药物化学有限公司 一种瑞舒伐他汀的制备方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260440A (en) * 1991-07-01 1993-11-09 Shionogi Seiyaku Kabushiki Kaisha Pyrimidine derivatives
US5856336A (en) * 1987-08-20 1999-01-05 Nissan Chemical Industries Ltd. Quinoline type mevalonolactones
WO2002081451A1 (fr) * 2001-04-05 2002-10-17 Nissan Chemical Industries, Ltd. Procede relatif a l'elaboration de 7-quinolinyl-3,5-dihydroxyhept-6-enoate
WO2003064392A1 (en) * 2002-01-31 2003-08-07 Novartis Ag Process for the manufacture of hmg-coa reductase inhibitors
WO2003087112A1 (en) * 2002-04-09 2003-10-23 Cls Laboratories, Inc. Chiral intermediate and process for the production thereof
WO2003097614A2 (en) * 2002-05-21 2003-11-27 Ranbaxy Laboratories Limited Process for the preparation of rosuvastatin
WO2007041666A1 (en) * 2005-10-04 2007-04-12 Teva Pharmaceutical Industries Ltd. Preparation of rosuvastatin
WO2007132482A2 (en) * 2006-05-17 2007-11-22 Manne Satyanarayana Reddy Novel process for the preparation of pitavastatin and its pharmaceutically acceptable salts

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856336A (en) * 1987-08-20 1999-01-05 Nissan Chemical Industries Ltd. Quinoline type mevalonolactones
US5260440A (en) * 1991-07-01 1993-11-09 Shionogi Seiyaku Kabushiki Kaisha Pyrimidine derivatives
WO2002081451A1 (fr) * 2001-04-05 2002-10-17 Nissan Chemical Industries, Ltd. Procede relatif a l'elaboration de 7-quinolinyl-3,5-dihydroxyhept-6-enoate
WO2003064392A1 (en) * 2002-01-31 2003-08-07 Novartis Ag Process for the manufacture of hmg-coa reductase inhibitors
WO2003087112A1 (en) * 2002-04-09 2003-10-23 Cls Laboratories, Inc. Chiral intermediate and process for the production thereof
WO2003097614A2 (en) * 2002-05-21 2003-11-27 Ranbaxy Laboratories Limited Process for the preparation of rosuvastatin
WO2007041666A1 (en) * 2005-10-04 2007-04-12 Teva Pharmaceutical Industries Ltd. Preparation of rosuvastatin
WO2007132482A2 (en) * 2006-05-17 2007-11-22 Manne Satyanarayana Reddy Novel process for the preparation of pitavastatin and its pharmaceutically acceptable salts

Also Published As

Publication number Publication date
KR20100096526A (ko) 2010-09-02
WO2010098583A2 (ko) 2010-09-02
KR101160152B1 (ko) 2012-06-27

Similar Documents

Publication Publication Date Title
WO2011073279A3 (fr) Procédé de traitement cosmétique impliquant un composé apte à condenser in situ
AP2012006191A0 (en) Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same.
WO2007093627A3 (de) Biozide zusammensetzung
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2010015657A3 (en) Alkoxypyrazoles and the process for their preparation
WO2010098583A3 (ko) 스타틴 화합물 또는 그 염의 신규 제조방법, 및 이에 사용되는 중간체 화합물
EP2729464B8 (en) Cyclopropyl-fused-1,3-thiazepines as bace 1 and/or bace 2 inhibitors
IL216728A0 (en) Novel method for preparing rosuvastatin. intermediated compounds useful for preparing same, and method for preparing same
WO2011132051A3 (en) Tricycle compounds as phosphodiesterase-10 inhibitors
WO2009124962A3 (en) Sulfonamides
WO2011047091A9 (en) Methods for treating traumatic brain injury
WO2012017321A3 (en) Treatment for dyslipidemia
WO2010012386A3 (en) Method for treating hypersensitive teeth
WO2011058525A3 (en) Processes for the preparation of erlotinib hydrochloride form a and erlotinib hydrochloride form b
WO2010136104A3 (en) Anti-dandruff agents
WO2010015656A3 (en) Alkoxypyrazoles and the process for their preparation
WO2010072770A3 (en) Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
WO2011073370A3 (fr) Utilisation du 2,3-dihydroxypropyl dodécanoate pour le traitement de la séborrhée
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
WO2012063115A3 (en) Process for the preparation of rosuvastatin calcium via novel amine intermediate
WO2011029639A3 (en) Compounds and methods for treating neoplasia
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
WO2012082942A3 (en) Neuropeptide analogs, compositions, and methods for treating pain
EP2634183B8 (en) Method for preparing 1,3,5-trioxane

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10746422

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10746422

Country of ref document: EP

Kind code of ref document: A2